The cutaneous predilection of disseminated cryptococcal infection in organ transplant recipients.
Moe
Kathleen
K
Lotsikas-Baggili
Angela J
AJ
Kupiec-Banasikowska
Agnieszka
A
Kauffman
Catharine Lisa
CL
D001741:Black or African American; D000935:Antifungal Agents / Q000627:therapeutic use; D001707:Biopsy, Needle; D003453:Cryptococcosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D003881:Dermatomycoses / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D018450:Disease Progression; D017809:Fatal Outcome; D016469:Fungemia / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D007150:Immunohistochemistry; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D017093:Liver Failure / Q000175:diagnosis / Q000601:surgery; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012720:Severity of Illness Index; D014181:Transplantation Immunology
D000935:Antifungal Agents